Correlation between clinical data and cytokines parameters in patients with Granulomatosis with Poilyangiitis (Wegener Granulomatosis)

by I. A. Lopatina, S. V. Moiseev, P. I. Novikov, L. I. Russu, E. I. Isaeva, M. V. Mezentseva
Published 2017-06-01

Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases

by S V Moiseev, P I Novikov, E N Semenkova, L A Strizhakov, S V Guliaev, T N Ianushkevich, N V Nikiforova, A D Meshkov, V V Panasiuk, Iu D Sorokin, M V Taranova, S A Parfenova, L V Dubrovskaia, E S Zhabina, E I Kuznetsova, I A Lopatina, N M Bulanov, N A Mukhin
Published 2013-05-01

Evaluation of the short-term efficacy and safety of biological agents in different rheumatic diseases: a multidisciplinary therapeutic hospital"s experience

by N A Mukhin, P I Novikov, Sergey Valentinovich Moiseev, T M Ignatova, L V Kozlovskaya, E N Semenkova, V V Fomin, S V Gulyaev, T N Krasnova, L A Strizhakov, T N Yanushkevich, V V Panasyuk, N V Nikiforova, S V Roshchupkina, Yu D Sorokin, A D Meshkov, L V Dubrovskaya, E S Zhabina, S A Parfenova, E I Kuznetsova, I A Lopatina
Published 2013-04-01